Literature DB >> 23686514

Rapid progression to pulmonary arterial hypertension crisis associated with mixed connective tissue disease in an 11-year-old girl.

Yuka Okura1, Shunichiro Takezaki, Yasuhiro Yamazaki, Masafumi Yamada, Ichiro Kobayashi, Tadashi Ariga.   

Abstract

Mixed connective tissue disease (MCTD) is rare in pediatric rheumatic diseases. Pulmonary arterial hypertension (PAH) associated with MCTD usually progresses gradually and is difficult to note at the asymptomatic phase. We report a 11-year-old girl with MCTD complicated with rapidly progressive PAH. Although PAH was not detected by echocardiogram or chest CT scan at the initial examination, it became clear in 1 year and suddenly came to cardiac arrest during an invasive procedure. She was successfully treated with extracorporeal assist and both vasodilative and immunosuppressive medication. A combination of echocardiogram and plasma BNP levels could be a useful marker for the follow-up of such cases. PAH could develop early in the course of pediatric MCTD and needs attention to unexpected acute exacerbation, especially under emotional stress.

Entities:  

Mesh:

Year:  2013        PMID: 23686514     DOI: 10.1007/s00431-013-2034-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

Review 1.  Pulmonary arterial hypertension in connective tissue diseases.

Authors:  Shunji Yoshida
Journal:  Allergol Int       Date:  2011-10-25       Impact factor: 5.836

2.  Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort.

Authors:  Yuichiro Shirai; Hidekata Yasuoka; Yutaka Okano; Tsutomu Takeuchi; Toru Satoh; Masataka Kuwana
Journal:  Rheumatology (Oxford)       Date:  2012-06-26       Impact factor: 7.580

Review 3.  Pediatric-onset mixed connective tissue disease.

Authors:  Richard J Mier; Michael Shishov; Gloria C Higgins; Robert M Rennebohm; Dorothy W Wortmann; Rita Jerath; Ekhlas Alhumoud
Journal:  Rheum Dis Clin North Am       Date:  2005-08       Impact factor: 2.670

Review 4.  Pulmonary hypertension in systemic sclerosis.

Authors:  Soumya Chatterjee
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

5.  Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.

Authors:  M A Burdt; R W Hoffman; S L Deutscher; G S Wang; J C Johnson; G C Sharp
Journal:  Arthritis Rheum       Date:  1999-05

Review 6.  Autoimmunity and pulmonary hypertension: a perspective.

Authors:  M R Nicolls; L Taraseviciene-Stewart; P R Rai; D B Badesch; N F Voelkel
Journal:  Eur Respir J       Date:  2005-12       Impact factor: 16.671

7.  The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).

Authors:  Fredrick M Wigley; Joao A C Lima; Maureen Mayes; David McLain; J Lincoln Chapin; Clive Ward-Able
Journal:  Arthritis Rheum       Date:  2005-07

8.  Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.

Authors:  Olivier Sanchez; Olivier Sitbon; Xavier Jaïs; Gérald Simonneau; Marc Humbert
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

9.  Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.

Authors:  Virginia Steen; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2003-02

10.  Structure of the small nuclear RNP particle U1: identification of the two structural protuberances with RNP-antigens A and 70K.

Authors:  B Kastner; U Kornstädt; M Bach; R Lührmann
Journal:  J Cell Biol       Date:  1992-02       Impact factor: 10.539

  10 in total
  2 in total

1.  Fatal Myocarditis in an Adolescent Girl with Evolving Connective Tissue Disease.

Authors:  Bipin Jose; Dantis Emmanuel; Preethy Harrison
Journal:  Indian J Pediatr       Date:  2019-05-10       Impact factor: 1.967

2.  Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide.

Authors:  Eri Sugawara; Masaru Kato; Ryo Hisada; Kenji Oku; Toshiyuki Bohgaki; Tetsuya Horita; Shinsuke Yasuda; Tatsuya Atsumi
Journal:  Intern Med       Date:  2017-02-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.